These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 36209227

  • 1. Moving towards a continuum of safer supply options for people who use drugs: A qualitative study exploring national perspectives on safer supply among professional stakeholders in Canada.
    Foreman-Mackey A, Pauly B, Ivsins A, Urbanoski K, Mansoor M, Bardwell G.
    Subst Abuse Treat Prev Policy; 2022 Oct 08; 17(1):66. PubMed ID: 36209227
    [Abstract] [Full Text] [Related]

  • 2. Community partner perspectives on the implementation of a novel safer supply program in Canada: a qualitative study of the MySafe Project.
    Mansoor M, Foreman-Mackey A, Ivsins A, Bardwell G.
    Harm Reduct J; 2023 Apr 28; 20(1):61. PubMed ID: 37118799
    [Abstract] [Full Text] [Related]

  • 3. A qualitative evaluation of a fentanyl patch safer supply program in Vancouver, Canada.
    Norton A, Ivsins A, Holliday E, Sutherland C, Kerr T, Kennedy MC.
    Int J Drug Policy; 2024 Sep 28; 131():104547. PubMed ID: 39159532
    [Abstract] [Full Text] [Related]

  • 4. Access and barriers to safer supply prescribing during a toxic drug emergency: a mixed methods study of implementation in British Columbia, Canada.
    Urbanoski KA, van Roode T, Selfridge M, Hogan KC, Fraser J, Lock K, McGreevy PB, Burmeister C, Barker B, Slaunwhite A, Nosyk B, Pauly B.
    Subst Abuse Treat Prev Policy; 2024 Sep 16; 19(1):44. PubMed ID: 39285270
    [Abstract] [Full Text] [Related]

  • 5. Safer opioid supply: qualitative program evaluation.
    Haines M, O'Byrne P.
    Harm Reduct J; 2023 Apr 20; 20(1):53. PubMed ID: 37081500
    [Abstract] [Full Text] [Related]

  • 6. Challenges of implementing safer supply programs in Canada during the COVID-19 pandemic: A qualitative analysis.
    Karamouzian M, Rafat B, Kolla G, Urbanoski K, Atkinson K, Bardwell G, Bonn M, Touesnard N, Henderson N, Bowles J, Boyd J, Brunelle C, Eeuwes J, Fikowski J, Gomes T, Guta A, Hyshka E, Ivsins A, Kennedy MC, Laurence G, Martignetti L, Nafeh F, Salters K, Tu D, Strike C, Pauly B, Werb D.
    Int J Drug Policy; 2023 Oct 20; 120():104157. PubMed ID: 37574645
    [Abstract] [Full Text] [Related]

  • 7. "If it wasn't for them, I don't think I would be here": experiences of the first year of a safer supply program during the dual public health emergencies of COVID-19 and the drug toxicity crisis.
    Kolla G, Pauly B, Cameron F, Hobbs H, Ranger C, McCall J, Majalahti J, Toombs K, LeMaistre J, Selfridge M, Urbanoski K.
    Harm Reduct J; 2024 Jun 07; 21(1):111. PubMed ID: 38849866
    [Abstract] [Full Text] [Related]

  • 8. Factors associated with obtaining prescribed safer supply among people accessing harm reduction services: findings from a cross-sectional survey.
    Palis H, Haywood B, McDougall J, Xavier CG, Desai R, Tobias S, Burgess H, Ferguson M, Liu L, Kinniburgh B, Slaunwhite AK, Crabtree A, Buxton JA.
    Harm Reduct J; 2024 Jan 06; 21(1):5. PubMed ID: 38184576
    [Abstract] [Full Text] [Related]

  • 9. People who use drugs' prioritization of regulation amid decriminalization reforms in British Columbia, Canada: A qualitative study.
    Xavier JC, McDermid J, Buxton J, Henderson I, Streukens A, Lamb J, Greer A.
    Int J Drug Policy; 2024 Mar 06; 125():104354. PubMed ID: 38402802
    [Abstract] [Full Text] [Related]

  • 10. Opportunities and challenges for implementing drug checking services in British Columbia, Canada: A qualitative study.
    Chayama KL, Ti L, Arredondo Sanchez Lira J, Coulaud PJ, Bardwell G, Knight R.
    Int J Drug Policy; 2024 Oct 06; 132():104560. PubMed ID: 39217815
    [Abstract] [Full Text] [Related]

  • 11. "It's just a perfect storm": Exploring the consequences of the COVID-19 pandemic on overdose risk in British Columbia from the perspectives of people who use substances.
    Foreman-Mackey A, Xavier J, Corser J, Fleury M, Lock K, Mehta A, Lamb J, McDougall J, Newman C, Buxton JA.
    BMC Public Health; 2023 Apr 03; 23(1):640. PubMed ID: 37013524
    [Abstract] [Full Text] [Related]

  • 12. Access to tablet injectable opioid agonist therapy in rural and smaller urban settings in British Columbia, Canada: a qualitative study.
    Bardwell G, Bowles JM, Mansoor M, Werb D, Kerr T.
    Subst Abuse Treat Prev Policy; 2023 Mar 03; 18(1):14. PubMed ID: 36869358
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prescribed safer supply during dual public health emergencies: a qualitative study examining service providers perspectives on early implementation.
    McCall J, Hobbs H, Ranger C, Cameron F, Stuart H, Nelken J, Majalahti J, Urbanoski K, Kolla G, LeMaistre J, Toombs K, Herriot R, Pauly B.
    Subst Abuse Treat Prev Policy; 2024 Mar 05; 19(1):19. PubMed ID: 38444035
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The potential impacts of community drug checking within the overdose crisis: qualitative study exploring the perspective of prospective service users.
    Wallace B, van Roode T, Pagan F, Hore D, Pauly B.
    BMC Public Health; 2021 Jun 16; 21(1):1156. PubMed ID: 34134698
    [Abstract] [Full Text] [Related]

  • 17. Substance use care innovations during COVID-19: barriers and facilitators to the provision of safer supply at a toronto COVID-19 isolation and recovery site.
    Kolla G, Tarannum CN, Fajber K, Worku F, Norris K, Long C, Fagundes R, Rucchetto A, Hannan E, Kikot R, Klaiman M, Firestone M, Bayoumi A, Laurence G, Hayman K.
    Harm Reduct J; 2024 Jan 20; 21(1):17. PubMed ID: 38243267
    [Abstract] [Full Text] [Related]

  • 18. Mapping a moral panic: News media narratives and medical expertise in public debates on safer supply, diversion, and youth drug use in Canada.
    Michaud L, Kolla G, Rudzinski K, Guta A.
    Int J Drug Policy; 2024 May 20; 127():104423. PubMed ID: 38642543
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.